Login
$REGN
$953.36 After hours

Who owns Regeneron?

Institutions own, across all of Regeneron's classes · 13F as of Q2 2026
88.1%
of the economics
76.1%
of the votes
Top 10 holders, by whole-company stake
Holder REGN Economics Votes
BlackRock, Inc. 9.1M 8.81% 7.61%
VANGUARD CAPITAL MANAGEMENT LLC 6.6M 6.41% 5.53%

Sign up to see all 10.

Top 10 together 42.3% of the economics · 36.5% of the votes
By class
Class Shares outstanding Held by institutions Votes a share Economics a share
REGN 101.6M 89.7% 1 vote 1
Class A 1.8M none filed 10 votes 1

SEC filing regn-20251231.htm: The Company's Restated Certificate of Incorporation, as amended, provides for the issuance of up to 40 million shares of Class A Stock, par value $0.001 per share, and 320 million shares of Common Stock, par value $0.001 per share. Shares of Class A Stock are convertible, at any time, at the option of the holder into shares of Common Stock on a share-for-share basis. Holders of Class A Stock ha...

How is ownership changing?

Institutions, last 8 quarters

A trend across this company's share classes isn't available yet: each quarter's 13F filings add up shares of classes that differ in economics and votes.

Biggest buyers in Q2 2026
  • Vanguard Portfolio Management LLC +1.5M
  • Norges Bank NEW +1.2M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • FMR LLC −686.2K
  • Price T Rowe Associates Inc /MD/ −647.8K

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$14.1M
14 notices from 8 people
Arranged in advance
100%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$3.1M$6.1MDecJan 2026: $1.2M under a 10b5-1 planJanFeb 2026: $3.2M under a 10b5-1 planFebMarAprMayJunJul 2026: $249.9K under a 10b5-1 planJulAug 2026: $960.0K under a 10b5-1 planAugSep 2026: $2.3M under a 10b5-1 planSepOct 2026: $6.1M under a 10b5-1 planOctNov
Largest proposed sellers
  • Murphy Andrew J Officer 10b5-1 $3.2M
  • McCourt Marion Officer 10b5-1 $2.99M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
−6.6%
−0.76% a year
Each share's claim on the business
+7.1%
grew without buying or selling a share
Spent on buybacks vs paid in stock
$18.1B vs $6.58B
over 10 fiscal years
Diluted shares, split-adjusted
105.3M111.4M117.5M2016: 116.3M shares'162017: 115.9M shares'172018: 114.8M shares'182019: 114.6M shares'192020: 115.1M shares'202021: 112.2M shares'212022: 113.5M shares'222023: 113.7M shares'232024: 115.1M shares'242025: 108.6M shares'25
Buybacks Stock-based comp
$0$2.92B$5.85B2016 buybacks: $02016 stock comp: $559.9M'162017 buybacks: $02017 stock comp: $507.3M'172018 buybacks: $4.4M2018 stock comp: $427.4M'182019 buybacks: $275.9M2019 stock comp: $464.3M'192020 buybacks: $5.85B2020 stock comp: $432.0M'202021 buybacks: $1.65B2021 stock comp: $601.7M'212022 buybacks: $2.08B2022 stock comp: $725.0M'222023 buybacks: $2.24B2023 stock comp: $885.0M'232024 buybacks: $2.6B2024 stock comp: $982.8M'242025 buybacks: $3.44B2025 stock comp: $993.7M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years80% 3–5 years8% 1–3 years8% Under 1 year5%
Quarterly turnover
9.4%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting Regeneron on Form 13F
B
BlackRock, Inc.
Shares
9.1M
% of company
—
Change vs last qtr
+165.8K (+1.9%)
Held since
≤2021
VC
Vanguard Capital Management LLC
Shares
6.6M
% of company
—
Change vs last qtr
−25.2K (−0.4%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding REGENERON PHARMACEUTICALS, INC., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting Regeneron on Form N-PORT
VT
Position value
$2.04B
% of company
—
% of the fund
0.09%
As of
June 30, 2026
DC
Dodge & Cox Funds
Position value
$1.95B
% of company
—
% of the fund
1.64%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding REGENERON PHARMACEUTICALS, INC. and how much of the fund the position is.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support